- AU$149.74m
- AU$106.76m
- AU$16.23m
Annual balance sheet for Orthocell, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11 | 24.8 | 20.6 | 28.6 | 44 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 23.5 | 0.843 | 1.21 | 1.85 | 2.85 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 35.3 | 26.9 | 23 | 31.8 | 49.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.4 | 1.61 | 2.56 | 2.33 | 3.32 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 37.9 | 29.6 | 26.6 | 35.2 | 54.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.82 | 4.53 | 5.31 | 6.4 | 8.34 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 28 | 23.5 | 22.1 | 20.7 | 20.4 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9.9 | 6.15 | 4.53 | 14.6 | 34.4 |
| Total Liabilities & Shareholders' Equity | 37.9 | 29.6 | 26.6 | 35.2 | 54.8 |
| Total Common Shares Outstanding |